The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS

Journal of Clinical Apheresis

Volumn 19, Issue 4, 2004, Pages 197-201

  Arpaci, Fikret ^a   Çetin, Türker ^a   Özet, Ahmet ^a   Oysul, Kaan ^a   Pekel, Aysel ^a   Ataergin, Selmin ^a   Kuzhan, Okan ^a   Kömürcü, Şeref ^a   Öztürk, Bekir ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

CD34 selection; Hematopoietic stem cell transplantation; Peripheral blood stem cells; Selection technologies

Indexed keywords

CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BREAST CANCER; CD34 SELECTION; CELL NUCLEUS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; LEUKAPHERESIS; MALE; MULTIPLE MYELOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDY; SCHOOL CHILD; T CELL DEPLETION;

ADOLESCENT; ADULT; ANTIGENS, CD34; BLOOD CELL COUNT; CELL COUNT; CELL NUCLEUS; CELL SEPARATION; CHILD; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROSPECTIVE STUDIES; STEM CELLS;

EID: 12844287551     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.20029     Document Type: Article

References (7)

1. + cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACs device. J Hematother Stem Cell Res. 2000;9:557-564.
2. Gryn J, Shadduck RK, Lister J, Zeigler ZR, Raymond JM. Factors affecting purification of CD34(+) peripheral blood stem cells using the Baxter Isolex 300i. J Hematother Stem Cell Res 2002;11:719-730.
3. Richel DJ, Johnsen HE, Canon J, Guillaume T, Schaafsma MR, Schenkeveld C, Hansen SW, McNiece I, Gringeri AJ, Briddell R, Ewen C, Davies R, Freeman J, Miltenyi S, Symann M. Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients. Bone Marrow Transplant 2000;25:243-249.
4. Schumm M, Lang P, Taylor G, Kuci S, Klingebiel T, Buhring HJ, Geiselhart A, Niethammer D, Handgretinger R. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999;8:209-218.
5. Johnsen HE, Hutchings M, Taaning E, Rasmussen T, Knudsen LM, Hansen SW, Andersen H, Gaarsdal E, Jensen L, Nikolajsen K, Kjaesgard E, Hansen NE. Selective loss of progenitor subsets following clinical CD34+ cell enrichment by magnetic field, magnetic beads or chromatography separation. Bone Marrow Transplant 1999;24:1329-1336.
6. Handgretinger R, Lang P, Schumm M, Taylor G, Neu S, Koscielnak E, Niethammer D, Klingebiel T. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 1998;21:987-993.
7. McNiece I, Briddel R, Stoney G, Kern B, Zilm K, Recktenwald D, Miltenyi S. Large-Scale isolation of CD34+ cells using the Amgen cell Selection Device results in high levels of purity and recovery. J Hematother 1997;6:5-11.